BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN TZID:Europe/Helsinki X-WR-TIMEZONE:Europe/Helsinki BEGIN:VEVENT UID:242@inflames.utu.fi DTSTART;TZID=Europe/Helsinki:20230322T000000 DTEND;TZID=Europe/Helsinki:20230322T133000 DTSTAMP:20230317T140806Z URL:https://inflames.utu.fi/events/inside-industry-lecture-visiting-profes sors-ellen-strahlman-and-reijo-salonen-2/ SUMMARY:Inside Industry lecture: Visiting Professors Ellen Strahlman and Re ijo Salonen DESCRIPTION:Welcome to listen Inside Industry InFLAMES lecture!\n\nYou are warmly welcome to the lecture of InFLAMES Visiting Professors Ellen Strahl man and Reijo Salonen titled “The Road Less Travelled: Career Pathways i n Industry and Beyond”.  The event is hosted by Academy Research Fellow Maija Hollmèn.\n\nThe lectures will be held in the Medisiina C Lecture H all Osmo Järvi on Wednesday March 22nd at 12:00-13:30.\nCoffee/tea and sa ndwiches are served at 11:45.\n\nEight students\, doctoral researchers and postdocs are welcome to have a “late” lunch with Ellen and Reijo afte r the seminar between 13:35-15:00. This is a great opportunity to discuss and learn more about their experiences. InFLAMES Flagship will offer the l unch.\nIf you got interested\, please register HERE\n\nIf you would like t o meet them in a one-on-one discussion between 15:00 and 17:00\, please co ntact directly InFLAMES Research Coordinator Sampo Koivunen (sampo.koivune n@utu.fi)\n\n\n\nEllen Strahlman\n\nEllen Strahlman has a degree in Bioche mical Sciences from Harvard University\, a medical degree from the Johns Hopkins School of Medicine and a Masters of Health Sciences degree from t he Bloomberg School of Public Health.  Her academic research focused on h er medical speciality\, ophthalmology\, and public health activities\, in cluding work in HIV.  She began working in the healthcare industry in 199 1\, and had a highly successful career with senior executive positions in several global companies.  Ellen was the Chief Medical Officer for Bect on Dickinson (BD)\, GlaxoSmithKline and Bausch &\; Lomb\; and was also the Head of Research and Development for BD and Bausch &\; Lomb.  In each of these roles\, her focus on innovation and leadership led to the a pproval and commercialization of dozens of new medicines\, vaccines and medical devices.  Ellen and her teams won several awards for their work\ , including Outstanding Corporate Innovator\, 2015 from Product Developmen t &\; Management Association\, MedTech Woman of the Year\, 2014 from Am erican Society of Mechanical Engineers\, Woman of Power &\; Influence A ward\, 2014 from National Organization of Women and Visionary Award\, 2011 from Foundation for Fighting Blindness.\n\n \;\n\n\n\nReijo Salonen\n \nProfessor Reijo Salonen graduated from the University of Turku as Licent iate in Medicine in 1983\, Doctor of Medicine in 1983\, and Specialist in Neurology in 1990. The University of Turku has granted him the title of Do cent of Neuroimmunology in 1989 and the title of Professor in 2009. Since 2018\, Salonen has worked as a partner in the consulting service company R eillen Group LLC in Florida. He is a member of the board in two pharmaceut ical companies\, Pharmasum AS and DelSiTech. His 25-year experience in pha rmaceutical industry include leading global development and medical affair s in Neurosciences at Pfizer and GlaxoSmithKline in the USA and all Resear ch and Development at Orion in Finland. Moreover\, Salonen has had multipl e positions in the boards of Finnish and international pharmaceutical rese arch and industry organisations over the last 15 years. Salonen was electe d as the Chief Technology Officer of the Year in 2017. ATTACH;FMTTYPE=image/jpeg:https://inflames.utu.fi/wp-content/uploads/2022/ 06/SalonenStrahlman.jpg CATEGORIES:Tapahtumat END:VEVENT BEGIN:VTIMEZONE TZID:Europe/Helsinki X-LIC-LOCATION:Europe/Helsinki BEGIN:STANDARD DTSTART:20221030T030000 TZOFFSETFROM:+0300 TZOFFSETTO:+0200 TZNAME:EET END:STANDARD END:VTIMEZONE END:VCALENDAR